ARCHIVES

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Majority Of U.S. Cancer Patients Receive High-Quality Care, ASCO Study Finds

July 29, 2005

St. Jude Offers Two Fellowships

July 18, 1986

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012